182 related articles for article (PubMed ID: 30602282)
1. Successful rituximab treatment of granulomatous/lymphocytic interstitial lung disease in common variable immunodeficiency.
Králíčková P; Kubcová Š; Kočová E; Bartoš V; Souček O; Rozsíval P; Vaníček H; Krčmová I; Ravčuková B; Grombiříková H; Freiberger T
Epidemiol Mikrobiol Imunol; 2018; 67(3):142-148. PubMed ID: 30602282
[TBL] [Abstract][Full Text] [Related]
2. Rituximab as a Single Agent for Granulomatous Lymphocytic Interstitial Lung Disease in Common Variable Immune Deficiency.
Tessarin G; Bondioni MP; Rossi S; Palumbo L; Soresina A; Badolato R; Plebani A; Lougaris V
J Investig Allergol Clin Immunol; 2019 Dec; 29(6):470-471. PubMed ID: 31825316
[No Abstract] [Full Text] [Related]
3. Efficacy of rituximab as a single-agent therapy for the treatment of granulomatous and lymphocytic interstitial lung disease in patients with common variable immunodeficiency.
Cereser L; De Carli R; Girometti R; De Pellegrin A; Reccardini F; Frossi B; De Carli M
J Allergy Clin Immunol Pract; 2019 Mar; 7(3):1055-1057.e2. PubMed ID: 30408616
[No Abstract] [Full Text] [Related]
4. Rituximab Monotherapy Is Effective as First-Line Treatment for Granulomatous Lymphocytic Interstitial Lung Disease (GLILD) in CVID Patients.
Tessarin G; Baronio M; Gazzurelli L; Rossi S; Chiarini M; Moratto D; Giliani SC; Bondioni MP; Badolato R; Lougaris V
J Clin Immunol; 2023 Nov; 43(8):2091-2103. PubMed ID: 37755605
[TBL] [Abstract][Full Text] [Related]
5. Common variable immunodeficiency-associated granulomatous and lymphocytic interstitial lung disease successfully treated with a combination regimen of rituximab and azathioprine.
Moctezuma SI; Panizo CM; Landecho MF
Med Clin (Barc); 2017 Oct; 149(7):312-313. PubMed ID: 28736065
[No Abstract] [Full Text] [Related]
6. Rituximab Monotherapy for Common Variable Immune Deficiency-Associated Granulomatous-Lymphocytic Interstitial Lung Disease.
Ng J; Wright K; Alvarez M; Hunninghake GM; Wesemann DR
Chest; 2019 May; 155(5):e117-e121. PubMed ID: 31060706
[TBL] [Abstract][Full Text] [Related]
7. Management of granulomatous lymphocytic interstitial lung disease in a patient with common variable immune deficiency.
Pathria M; Urbine D; Zumberg MS; Guarderas J
BMJ Case Rep; 2016 Jun; 2016():. PubMed ID: 27335365
[TBL] [Abstract][Full Text] [Related]
8. Rituximab and antimetabolite treatment of granulomatous and lymphocytic interstitial lung disease in common variable immunodeficiency.
Verbsky JW; Hintermeyer MK; Simpson PM; Feng M; Barbeau J; Rao N; Cool CD; Sosa-Lozano LA; Baruah D; Hammelev E; Busalacchi A; Rymaszewski A; Woodliff J; Chen S; Bausch-Jurken M; Routes JM
J Allergy Clin Immunol; 2021 Feb; 147(2):704-712.e17. PubMed ID: 32745555
[TBL] [Abstract][Full Text] [Related]
9. FDG PET-CT imaging of therapeutic response in granulomatous lymphocytic interstitial lung disease (GLILD) in common variable immunodeficiency (CVID).
Jolles S; Carne E; Brouns M; El-Shanawany T; Williams P; Marshall C; Fielding P
Clin Exp Immunol; 2017 Jan; 187(1):138-145. PubMed ID: 27896807
[TBL] [Abstract][Full Text] [Related]
10. Rituximab as a single agent for successful treatment of granulomatous and lymphocytic interstitial lung disease in a pediatric patient with common variable immunodeficiency.
Kosinski SM; Nachajon RV; Milman E
J Allergy Clin Immunol Pract; 2022 Mar; 10(3):876-878.e1. PubMed ID: 34718215
[No Abstract] [Full Text] [Related]
11. Intravenous Immunoglobulin Monotherapy for Granulomatous Lymphocytic Interstitial Lung Disease in Common Variable Immunodeficiency.
Hasegawa M; Sakai F; Okabayashi A; Sato A; Yokohori N; Katsura H; Asano C; Kamata T; Koh E; Sekine Y; Hiroshima K; Ogura T; Takemura T
Intern Med; 2017 Nov; 56(21):2899-2902. PubMed ID: 28924106
[TBL] [Abstract][Full Text] [Related]
12. [Granulomatous lymphocytic interstitial lung disease (GLILD) as a manifestation of pulmonary changes in common variable immunodeficiency (CVID) – case report].
Marciszewska E; Szaflarska A; Pituch-Noworolska A
Przegl Lek; 2016; 73(7):530-3. PubMed ID: 29677427
[TBL] [Abstract][Full Text] [Related]
13. Common variable immunodeficiency with granulomatous-lymphocytic interstitial lung disease and preceding neurological involvement: a case-report.
Cowen JE; Stevenson J; Paravasthu M; Darroch J; Jacob A; Tueger S; Gosney JR; Simons A; Spencer LG; Judge EP
BMC Pulm Med; 2020 Jul; 20(1):205. PubMed ID: 32736614
[TBL] [Abstract][Full Text] [Related]
14. Serum IL-12 and soluble IL-2 receptor levels as possible biomarkers of granulomatous and lymphocytic interstitial lung disease in common variable immunodeficiency: a case report.
Vitale J; Convers KD; Goretzke S; Guzman M; Noyes B; Parkar N; Knutsen AP
J Allergy Clin Immunol Pract; 2015; 3(2):273-6. PubMed ID: 25609323
[No Abstract] [Full Text] [Related]
15. Granulomatous-Lymphocytic Interstitial Lung Disease in a Patient With Common Variable Immunodeficiency.
Shah JL; Amin SB; Verma N; Mohammed TL
Curr Probl Diagn Radiol; 2018; 47(4):282-284. PubMed ID: 28583689
[TBL] [Abstract][Full Text] [Related]
16. Granulomatous-lymphocytic interstitial lung disease as the first manifestation of common variable immunodeficiency.
Tashtoush B; Memarpour R; Ramirez J; Bejarano P; Mehta J
Clin Respir J; 2018 Jan; 12(1):337-343. PubMed ID: 27243233
[TBL] [Abstract][Full Text] [Related]
17. Granulomatous-lymphocytic interstitial lung disease (GLILD) in common variable immunodeficiency (CVID).
Park JH; Levinson AI
Clin Immunol; 2010 Feb; 134(2):97-103. PubMed ID: 19900842
[TBL] [Abstract][Full Text] [Related]
18. Clinical Predictors of a Diagnosis of Common Variable Immunodeficiency-related Granulomatous-Lymphocytic Interstitial Lung Disease.
Mannina A; Chung JH; Swigris JJ; Solomon JJ; Huie TJ; Yunt ZX; Truong TQ; Brown KK; Achcar RD; Olson AL; Cox CW; Kligerman SJ; Curran-Everett D; Fernández Pérez ER
Ann Am Thorac Soc; 2016 Jul; 13(7):1042-9. PubMed ID: 27064856
[TBL] [Abstract][Full Text] [Related]
19. X-linked Inhibitor of Apoptosis Complicated by Granulomatous Lymphocytic Interstitial Lung Disease (GLILD) and Granulomatous Hepatitis.
Steele CL; Doré M; Ammann S; Loughrey M; Montero A; Burns SO; Morris EC; Gaspar B; Gilmour K; Bibi S; Shendi H; Devlin L; Speckmann C; Edgar DM
J Clin Immunol; 2016 Oct; 36(7):733-8. PubMed ID: 27492372
[TBL] [Abstract][Full Text] [Related]
20. Successful Treatment of Granulomatous-lymphocytic Interstitial Lung Disease in a Patient with CTLA-4 Deficiency.
Nishimura M; Miyata J; Tanigaki T; Nomura S; Serizawa Y; Igarashi S; Itou K; Ohno T; Kurata Y; Kimizuka Y; Fujikura Y; Sekinaka Y; Sekinaka K; Matsukuma S; Nonoyama S; Kawana A
Intern Med; 2023 Mar; 62(6):871-875. PubMed ID: 35945007
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
